India to Brazil: Trastuzumab Export Trade Route

The India to Brazil Trastuzumab corridor is one of India's established pharmaceutical export routes, with 91 shipments documented worth a combined $4.1M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 42% of all export value, reflecting the consolidated nature of India's trastuzumab manufacturing sector.

Across 10 active suppliers, the average shipment value stands at $45.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with trastuzumab's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 33.0%, placing it at rank #9 among India's top trastuzumab export destinations globally.

On the import side, key buyers of Indian trastuzumab in Brazil include LIBBS FARMACEUTICA LTDA., BIOCON BIOLOGICS UK LIMITED, TO THE ORDER OF and 16 others. LIBBS FARMACEUTICA LTDA. is the single largest importer with 4 shipments valued at $1.7M USD.

India's trastuzumab exports to Brazil are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, BIOCON BIOLOGICS INDIA LIMITED, SPECIALITY MEDICINES LIMITED — together account for 86% of total trade value on this route. The average shipment value of $45.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as trastuzumab lyophilized powder for injection (r-dna origin) 440mg/vial. batch no. 7802489 and trastuzumab lyophilized powder for injection (r-dna origin) 440mg/vial. batch no. 7802490, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LIBBS FARMACEUTICA LTDA. is the largest importer with 4 shipments worth $1.7M USD — representing 42% of all trastuzumab imports from India on this route. A total of 19 buyers are active on this corridor.